Urokinase vs Tissue-Type Plasminogen Activator for Thrombolytic Evacuation of Spontaneous Intracerebral Hemorrhage in Basal Ganglia

Urokinase vs Tissue-Type Plasminogen Activator for Thrombolytic Evacuation of Spontaneous Intracerebral Hemorrhage in Basal Ganglia

Spontaneous intracerebral hemorrhage (ICH) is a devastating form of stroke, which leads to a high rate of mortality and poor neurological outcomes worldwide. Thrombolytic evacuation with urokinase-type plasminogen activator (uPA) or tissue-type plasminogen activator (tPA) has been showed to be a hop...

Full description

Bibliographic Details
Main Authors:	Yuqian Li, Ruixin Yang, Zhihong Li, Bo Tian, Xingye Zhang, Jiancai Wang, Longlong Zheng, Boliang Wang, Lihong Li
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2017-08-01
Series:	Frontiers in Neurology
Subjects:	intracerebral hemorrhage thrombolytic evacuation urokinase tissue-type plasminogen activator basal ganglia
Online Access:	http://journal.frontiersin.org/article/10.3389/fneur.2017.00371/full

Similar Items

Evaluation of Urokinase Plasminogen Activator Receptor, Soluble Urokinase Plasminogen Activator Receptor, and β1 Integrin in Patients with Hodgkin′s Lymphoma
by: Shirin Kouhpayeh, et al.
Published: (2017-01-01)

The Contribution of the Urokinase Plasminogen Activator and the Urokinase Receptor to Pleural and Parenchymal Lung Injury and Repair: A Narrative Review
by: Torry A. Tucker, et al.
Published: (2021-02-01)

Specific inhibitors of urokinase plasminogen activator for treatment of cancers; In silico approach
by: Benjamin Talbot, et al.
Published: (2020-05-01)

Reduced Expression of Urokinase Plasminogen Activator in Brown Adipose Tissue of Obese Mouse Models
by: Chung-Ze Wu, et al.
Published: (2021-03-01)

Urokinase-type plasminogen activator is a modulator of synaptic plasticity in the central nervous system: implications for neurorepair in the ischemic brain
by: Manuel Yepes
Published: (2020-01-01)

Serum levels of urokinase-type plasminogen activator in healthy dogs and oncologic canine patients
by: Sofia C. Ramos, et al.
Published: (2017-08-01)

Urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type-1 (PAI-1) in breast cancer - correlation with traditional prognostic factors
by: Lampelj Maja, et al.
Published: (2015-12-01)

Urokinase plasminogen activator expression in canine malignant mammary tumours by immunohistochemical study
by: Golshahi Hannaneh, et al.
Published: (2013-12-01)

Concentrations of plasminogen activator inhibitor-1 (PAI-1) and urokinase plasminogen activator (uPA) in induced sputum of asthma patients after allergen challenge
by: Krzysztof Kowal,, et al.
Published: (2010-04-01)

Inhibitory effects of wogonin on invasion by human oral cancer cells by decreasing the activity of matrix metalloproteinases and urokinase-plasminogen activator
by: Yung-Chuan Ho, et al.
Published: (2014-06-01)

Monitoring of chemotherapy successfulness of Platina/Taxol chemotherapy protocol by using determination of serum urokinase plasminogen activator (uPA) and soluble urokinase plasminogen activator receptor (suPAR) in patients with ovarian carcinoma FIGO II
by: Dženita Ljuca, et al.
Published: (2007-05-01)

Soluble urokinase plasminogen activator receptor and its complicated role in hemodialysis (HD) patients with Covid-19 infection
by: Ioannis Griveas, et al.
Published: (2021-07-01)

Association between serum soluble urokinase-type plasminogen activator receptor and atrial fibrillation
by: Noboru Ichihara, et al.
Published: (2017-10-01)

Experimental and Clinical Evidence Supports the Use of Urokinase Plasminogen Activation System Components as Clinically Relevant Biomarkers in Gastroesophageal Adenocarcinoma
by: Gary Tincknell, et al.
Published: (2021-08-01)

Urokinase-type Plasminogen Activator and Plasminogen Activator Inhibitor Induction by Etoposide in a Glioblastoma Cell Strain
by: Branko Brdar, et al.
Published: (2002-01-01)

Successful thrombolytic therapy with recombinant tissue-type plasminogen activator for massive pulmonary embolism -A case report-
by: Min Soo Kim, et al.
Published: (2010-07-01)

Fibrinolysis regulation by platelets retaining plasminogen and tissue-type plasminogen activator on their surface
by: T. Grinenko, et al.
Published: (2019-12-01)

Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and Its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic Applications
by: Niaz Mahmood, et al.
Published: (2018-02-01)

Soluble Urokinase Plasminogen Activator Receptor (suPAR) Concentrations Are Elevated in Patients with Neuroendocrine Malignancies
by: Burcin Özdirik, et al.
Published: (2020-05-01)

Soluble urokinase-type plasminogen activator receptor as a biomarker of treatment response in childhood tuberculosis
by: Ery Olivianto, et al.
Published: (2019-01-01)

Deficiency of Urokinase Plasminogen Activator May Impair β Cells Regeneration and Insulin Secretion in Type 2 Diabetes Mellitus
by: Chung-Ze Wu, et al.
Published: (2019-11-01)

Inhibition of Urokinase-Type Plasminogen Activator Expression by Macelignan in Porphyromonas gingivalis Supernatant-Induced Human Oral Epithelial Cells
by: YANTI
Published: (2010-03-01)

Inhibition of Urokinase-Type Plasminogen Activator Expression by Macelignan in Porphyromonas gingivalis Supernatant-Induced Human Oral Epithelial Cells
by: YANTI
Published: (2010-03-01)

Effect of remission induction therapy on the level of soluble urokinase plasminogen activator receptor in acute myeloid leukemia
by: Eman Qassim Ahmed, et al.
Published: (2020-01-01)

Value of soluble Urokinase plasminogen activator receptor over age as a biomarker of impaired myocardial relaxation
by: Angela S. Koh, et al.
Published: (2017-11-01)

The effect of anti-human plasminogen monoclonal antibodies on Glu-plasminogen activation by plasminogen activators
by: M. Akrami, et al.
Published: (2006-07-01)

Intravenous Thrombolytic Therapy in Acute Ischemic Stroke
by: Semai Bek, et al.
Published: (2009-12-01)

Serum levels of soluble urokinase plasminogen activator receptor as a new inflammatory marker in adolescent obesity
by: Ummugulsum Can, et al.
Published: (2017-01-01)

MicroRNA-645 targets urokinase plasminogen activator and decreases the invasive growth of MDA-MB-231 triple-negative breast cancer cells
by: Meng D, et al.
Published: (2018-11-01)

Intracerebral Hemorrhage Due to Intravenous Thrombolytic Treatment in Acute Ischemic Stroke
by: Yaprak Seçil, et al.
Published: (2017-04-01)

Studying the Activity of Fibroblast Growth Factor 18 and Urokinase Plasminogen Activator Receptor Promoters in Two Colon Cancer Cell Lines
by: Ladan Teimoori-Toolabi, et al.
Published: (2009-01-01)

Explication of the roles of prostate health index (PHI) and urokinase plasminogen activator (uPA) as diagnostic and predictor tools for prostate cancer in equivocal PSA range of 4–10 ng/mL
by: Anmar M. Nassir, et al.
Published: (2020-08-01)

Predictive value of plasma soluble urokinase-type plasminogen activator receptor for post-severe traumatic multiple organ dysfunction syndrome
by: ZHAO Yinjie, et al.
Published: (2021-04-01)

Use of thrombolytic therapy in cerebral venous sinus thrombosis with ulcerative colitis
by: Kavitha Kothur, et al.
Published: (2012-01-01)

Plasminogen Activators in Neurovascular and Neurodegenerative Disorders
by: Manuel Yepes, et al.
Published: (2021-04-01)

<i>N</i>-Alkylisatin-Loaded Liposomes Target the Urokinase Plasminogen Activator System in Breast Cancer
by: Lisa Belfiore, et al.
Published: (2020-07-01)

Soluble urokinase-type plasminogen activator receptor as a measure of treatment response in acute exacerbation of COPD
by: Gehan Hassan AboEl-Magd, et al.

Aspirin Inhibits IKK-β-mediated Prostate Cancer Cell Invasion by Targeting Matrix Metalloproteinase-9 and Urokinase-Type Plasminogen Activator
by: Chongjun Shi, et al.
Published: (2017-03-01)

Inhibitors of Urokinase Type Plasminogen Activator and Cytostatic Activity from Crude Plants Extracts
by: Augusto Carvajal, et al.
Published: (2013-07-01)

Contribution of Streptokinase-Domains from Groups G and A (SK2a) Streptococci in Amidolytic/Proteolytic Activities and Fibrin-Dependent Plasminogen Activation: A Domain-Exchange Study
by: Maryam Rafipour, et al.
Published: (2020-01-01)

Cannot write session to /tmp/vufind_sessions/sess_qpbot7d4u5585c5fbh7qd3mprt